Merial Limited

Institut National De La Recherche Agronomique

Rhone Merieux

Philippe Desmettre

Jacques Samarut

Catherine Cleuziat

Jean-Fran&ccedil;ois Bouquet

Miloud Benchaïbi

Bernard Languet

Jean-François Bouquet

Miloud Bencha&iuml;bi

Jean-Francois Bouquet

The invention features non-transformant immortal avian cells, in particular derived from avian tissues, i.e., other than blood or hematopoietic cells, particularly fibroblasts and epithelial cells, for instance of embryos. The avian cells are immortalized by the SV40 T+t gene in the dependence of the MTI promoter. In particular they integrate the pDAMT vector.

Immortalized avian cell lines

The invention features apoptosis-resistant, non-transformant immortalised avian cells, in particular, avian tissues, i.e., other than blood or haematopoietic cells, particularly fibroblasts and epithelial cells, for instance embryos.

Producing viruses utilizing immortal avian cells

The invention features non-transformant immortal avian cells, in particular derived from avian tissues, i.e. other than blood or haemotopoietic cells, particularly fibroblasts and epithelial cells, for instance of embryos. The avian cells are immortalized by the SV40 T&plus;t gene in the dependence of the MTI promoter. In particular they integrate the pDAMT vector.

Immortal avian cells

The therapeutic elements for oral administration of medication to animals comprise an active principle contained in a craved for envelope. The envelope (1) comprises, in admixture, one or more craved for materials and one or more substances agglomerating the craved for materials, the envelope possessing a high mechanical and thermal resistance, and being previously formed into a hollow shape appropriate for consumption by the animal, and defining an internal volume, such internal volume being filled by a craved for binder (3) and comprising the active principle (2), the binder closely conforming the internal shape of the envelope (1) in order to provide a continuity between the envelope (1) and the active principle (2).

Therapeutic elements for the oral administration of medication to

Growing community of inventors

Ecully, France

Philippe Desmettre